Key Trends and Insights into the 3D Cell Culture Technologies Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the 3d cell culture technologies market grown in recent years?
In recent times, the market size for 3D cell culture technologies has experienced a quick expansion. It is forecasted to increase from $3.36 billion in 2024 to $3.99 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 18.9%. The expansion during the historical period is credited to progress in cell biology, drug enhancement, a rise in chronic illnesses, and government financial backing.
How is the 3d cell culture technologies market size expected to evolve during the forecast period?
Predictions indicate a significant surge in the market size of 3D cell culture technologies in the coming years. The market is projected to expand to $8.33 billion in 2029, with a compound annual growth rate (CAGR) of 20.2%. This anticipated growth during the forecast period can be linked to factors such as the pharmaceutical industry, escalated research and development, and considerations of the environment and ethics. Major trending movements throughout this forecasted period include personalized medicine, breakthroughs in technology, bioprinting, and regenerative medicine.
Get your 3d cell culture technologies market report here!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2462&type=smp
Which key drivers are propelling the 3d cell culture technologies market’s growth?
The escalating need for organ transplant has been a key driving force behind the growth in the 3D Cell Culture Technologies Market. With the ability to create three-dimensional cell structures, 3D cell culture technology enables the creation of tissue and organ duplicates. This holds great importance in organ transplantation. Moreover, 3D cell structures can support the reproduction of cells for organ and tissue regeneration and offer a platform for drug toxicity testing. In January 2023, the United Network for Organ Sharing (UNOS), a non-profit organization based in the US, released data indicating that 42,887 organ transplants were successfully carried out in the country in 2022. This represents a 3.7% increase from 2021. Furthermore, there were 14,903 deceased organ donors in the country in 2022, marking a 7.5% increase from the previous year. This also marked the twelfth consecutive year where deceased donations set a record. With more relaxed eligibility criteria for deceased organ donors based on positive clinical experiences, the population of donors from less traditional groups has been on the rise. In the same year, 4,776 donations were made after circulatory death (DCD donors), improving the previous year’s record by up to 14%. There were also 5,789 deceased donors over the age of 50, this was the first time more than 5,000 donors from this age group were recorded in a year.
What are the market segments in the 3d cell culture technologies industry?
The 3D cell culture technologies market covered in this report is segmented –
1) By Type: Scaffold-based, Scaffold-free, 3D Bioreactors
2) By Application: Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine
3) By End Users: Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users
Subsegments:
1) By Scaffold-Based: Natural Scaffolds, Synthetic Scaffolds, Hybrid Scaffolds
2) By Scaffold-Free: Spheroid-Based, Organoid-Based
3) By 3D Bioreactors: Spinner Flask Bioreactors, Rotating Wall Bioreactors, Microcarrier-Based Bioreactors, Hollow Fiber Bioreactors
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2462&type=smp
Which leading companies are shaping the growth of the 3d cell culture technologies market?
Major companies operating in the 3D cell culture technologies market include Becton Dickinson and Company, Corning Incorporated, Eppendorf AG, GE Healthcare a division of General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, HiMedia Laboratories Pvt. Ltd., Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, Greiner Bio-One International GmbH, Irvine Scientific Sales Company Inc., Cell Culture Company LLC, SeraCare Life Sciences Inc., American Type Culture Collection (ATCC), Miltenyi Biotec B.V. & Co. KG, AITbiotech Pte Ltd, Essen BioScience a Sartorius Company, Sigma-Aldrich, Bel-Art Products Inc., MilliporeSigma, Sumitomo Bakelite, EMD Millipore, Affymetrix Inc., VWR International llc., WHEATON IndustriesInc, Sartorius AG, CN Bio Innovations, Nortis Inc., Kiyatec, Nanofiber Solutions, Copner Biotech, Known Medicine, Synthecon Inc., 3D Biotek LLC, 3D Cell Culture Innovations LLC., 3D Matrix Inc., Allevi Inc., BioSpherix Ltd., Emulate Inc., MicroTissues Inc.
What key trends are currently impacting the 3d cell culture technologies market’s development?
The incorporation of advanced technology is the most recent trend witnessed in the 3D Cell culture market. A good illustration of this is the utilization of the vivo/vitro environment by numerous companies, which introduces a significant advancement in the 3D cell culture market. While the models under 2D cell expansion and interactions are not suitable in vitro, the 3D cell culture method provides a more conducive cell culture setting. The Vitro environment allows the procedure to be undertaken externally in a controlled setting, offering the immense benefit of monitoring patient health. This method is gathering momentum due to its importance in medical procedures. The FDA has given its approval for Biotek’s 3D cell expansion system to be applied as a medical apparatus. It has additionally approved Biotek’s Polycaprolactone (PCL), a biodegradable polyester used in several FDA-approved implants and drug delivery devices.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2462
Which geographic areas are influencing the growth of the 3d cell culture technologies market?
North America was the largest region in the 3D cell culture technologies market in 2023. Western Europe was the second largest region in the 3D cell culture technologies market. The regions covered in the 3D cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Cell Culture Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report
Single Use Bioprocessing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report
Gene Editing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: